Divarasib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Divarasib
Jan 10, 2024, 18:21 |
Blog
Top Precision Oncology articles of 2023 by Vivek Subbiah
Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…
Aug 27, 2023, 18:58 |
Insight
Vivek Subbiah: The 3rd KRAS G12C kid on the block.
According to Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute:…
Aug 27, 2023, 18:50 |
Insight
Anirban Maitra: The phase 1 data of Genentech’s KRAS G12C inhibitor Divarasib was published yesterday in NEJM.
In a Twitter post by Anirban Maitra, a Professor of Pathology and Translational Molecular Pathology,…
All:
3
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube